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Purpose
• To compare abstinence rates among 
patients receiving medication- assisted 
treatment (MAT) who were referred to 12-
step programs to those only receiving 
MAT.
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Background
•Overdose deaths in the U.S. from opioids 
have dramatically increased since the 
COVID-19 pandemic
•Although MAT programs are widely 
available for sufferers of opiate addiction, 
many drop out of treatment prematurely
•Twelve-step programs are considered a 
valuable part of treatment, but few studies 





•  Study Population
•English-speaking, ≥ 18 years
•DSM5 OUD diagnosis, on buprenorphine
• Primary Endpoint
•Change in positive UDS over 6 mo. 
between subjects and controls
Results
Enrollment Barriers
• Excluding new patients and those attending virtual 
visits
• High percentage of patients who missed 
appointments
• Lack of staff referrals
• Time constraints by both staff and patients
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Implications for Practice
•Low enrollment limited our ability to 
determine whether combining medication 
management with a 12-step program 
improves abstinence.
•Failure to keep appointments is common 
among patients with OUD, and virtual 
meetings are becoming more prevalent 
post-COVID.
•Developing effective enrollment strategies 
is necessary to evaluate the effectiveness 
of combined treatment.
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